
SR&ED Tax Credits for
Doctors & Medical Research
Treating patients using established protocols isn't SR&ED—but conducting clinical trials and developing novel therapeutics to overcome biological uncertainties is. We translate your clinical data into audit-proof claims, so you can focus on advancing medicine, not navigating tax codes.


































What may qualify in doctors & medical research
Conducting Phase I/II/III clinical trials for new treatments
Developing novel therapeutic protocols for treatment-resistant conditions
Researching new diagnostic or screening methodologies
Surgical innovation and testing novel operative techniques
Translational research bridging bench science to bedside application
Do you qualify?
A quick self-check
Technological Uncertainty
Systematic Investigation
Scientific Advancement
We help you capture:
What problem you were solving
What problem you were solving
What problem you were solving
Our technical specialists speak your language.
Whether you are architecting a cloud database, scaling a bioreactor, or overcoming mechanical failure, we understand your underlying constraints without needing a beginner's explanation.
What problem you were solving
What problem you were solving
Common pitfalls we help you avoid
Routine Care vs. R&D
The "Complex Patient" Trap
Patient Privacy (PIPEDA/PHIPA)
Corporate Structure Issues
How Checkpoint helps doctors & medical research teams with SR&ED
Entry consultation
Eligibility review
Technical discovery
Claim Preparation & Submission
Proactive Compliance
CRA Audit and Review Defense
Funding Secured
What evidence
matters most
Technical
Uncertainty
Systematic Investigation
Technological Advancement
We help you capture:
What problem you were solving
What you changed vs. what stayed constant
What you measured
What changed based on results
Who worked on it and when
Link between trial work and eligible costs
Explore healthcare sub-sectors
Dental & Orthodontics
Healthcare & MedTech Overview
Why teams choose Checkpoint
“Checkpoint Research brought a level of technical literacy that made our technical reviews incredibly efficient.
Frequently Asked Questions
We speak your technical language
What is the CRA’s "Why and How" framework?
The "Why and How" framework is the CRA’s current assessment standard, replacing the legacy "Five Questions." It strictly evaluates the technical impetus for your project (the 'Why') and the systematic rigor of your execution (the 'How').
What constitutes "contemporaneous documentation"?
Contemporaneous documentation refers to raw evidence generated during the execution of the work. Retroactive documentation drafted months after project completion is heavily scrutinized and frequently rejected by the CRA.
Which specific artifacts should our engineering team preserve?
Preserve time-stamped artifacts tied directly to technical roadblocks. Commit logs, Jira/Linear tickets, Slack threads detailing failed tests, architecture whiteboard photos, and granular timesheets are the gold standard of evidence.
What are the escalation protocols if a claim is denied?
The CRA provides a strict, three-tier escalation framework: an initial dispute resolution dialogue with the reviewer, an escalation to the Review Manager, and ultimately a formal Notice of Objection — filed within 90 days of assessment and, if required, carried to the Tax Court of Canada.
When is litigation in the Tax Court of Canada (TCC) necessary?
The TCC is the final arbiter, utilized only when internal CRA administrative appeals are exhausted. It provides an independent judicial review of your technical and financial eligibility, completely separate from the CRA's internal ecosystem.
Let’s Assess Your R&D Potential
+1 (365) 525-2505